The Program
For 23 years, this premier gathering of healthcare professionals involved in the treatment of lung cancer continues to differentiate itself from other meetings in the field of thoracic oncology by offering a broad scope of topics essential for practicing oncologists and clinicians. The conference offers a comprehensive update on lung cancer screening and smoking cessation, biomarker testing, management of lung cancer across the spectrum of disease stages and NSCLC, SCLC, mesothelioma, and thoracic tumors.
Join us for this unparalleled learning experience offering significant developments in the field of thoracic oncology.
THE Highlights
- Liquid biopsy
- Lung cancer screening
- Smoking cessation
- Locally advanced NSCLC
- Early-stage non-small cell lung cancer (NSCLC)
- Adjuvant therapy
- Mesothelioma
- Squamous cell carcinoma
- Thymic tumors
- The new staging system
- Advanced NSCLC
- Supportive therapy
- Biomarkers and targeted therapy
- Immunotherapy
23+
YEARS OF INNOVATION20+
EXPERT FACULTY MEMBERS12.5+
AMA/CMECREDITS
The Faculty
Hear from a lineup of more than 20 expert thought leaders pioneering the field of thoracic oncology.
The Essentials
